CAMP4 is a biotechnology company focused on developing innovative treatments for SYNGAP1-related disorders. The company is dedicated to advancing first-in-class therapies to address the unmet medical needs of patients with these genetic conditions.
Leadership & Board
Currently, no data available
Latest Estimated Valuation
Estimated Valuation―
Estimated Valuation―
Total Amount Raised$100M
Total Amount Raised$100M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$100M
Latest Funding Amount$100M
Latest Funding RoundInvestment
Latest Funding RoundInvestment
Post-Money Valuation―
Post-Money Valuation―
Funding Round
Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Sep 10, 2025
Investment
$100.00M
―
Similar Companies
A snapshot of private companies similar to $CAMP camp4, helping you discover and navigate related company profiles.